Want to see SG:8K7 full AI Analyst Report?
8K7 Stock Chart & Stats
S$0.10
>-S$0.01(-3.23%)
At close: 4:00 PM EST
S$0.10
>-S$0.01(-3.23%)
Day’s Range― - ―
52-Week RangeS$0.07 - S$0.11
Previous CloseN/A
Volume145.10K
Average Volume (3M)131.00K
Market Cap
S$48.66M
Enterprise ValueS$73.97M
Total Cash (Recent Filing)S$45.13M
Total Debt (Recent Filing)S$28.46M
Price to Earnings (P/E)―
Beta0.82
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding623,825,800
10 Day Avg. Volume276,890
30 Day Avg. Volume131,003
Financial Highlights & Ratios
PEG Ratio0.48
Price to Book (P/B)0.43
Price to Sales (P/S)0.47
P/FCF Ratio-8.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthA 51.77% top-line increase indicates expanding demand and market traction in gloves and consumables. Sustained revenue growth provides scale benefits, helps absorb fixed costs, and creates a platform for margin recovery if operational efficiencies and pricing discipline are maintained over the medium term.
Solid Balance Sheet BaseModerate leverage (D/E 0.30) and a high equity ratio (68.33%) give the company financial stability and borrowing capacity. This robust equity base reduces solvency risk, supports capital spending or working-capital needs, and provides time to address operating issues without aggressive refinancing.
Vertically Integrated ModelCombining manufacturing with branded distribution creates control over supply, cost structure, and margin capture. Vertical integration reduces reliance on third-party suppliers, supports differentiated product offerings and channel control, and can produce durable competitive advantages in supply-constrained markets.
Bears Say
Weak ProfitabilityNegative net and EBIT margins show the company is not converting sales into sustainable profits. Structural margin pressure—from costs, pricing, or mix—will constrain internal reinvestment and limit ability to build reserves; persistent losses undermine long-term viability unless margins improve.
Deteriorating Cash GenerationA steep fall in free cash flow and negative operating cash flow versus net income signal material strain on liquidity and core cash generation. Weak cash flow restricts capex funding, working capital, and debt servicing capacity, increasing reliance on external financing and elevating execution risk.
Poor Returns To EquityNegative ROE indicates the company is destroying shareholder value rather than creating it. Combined with EPS deterioration, this suggests issues with profitability, capital allocation, or operating leverage that must be corrected to restore investor confidence and enable sustainable long-term returns.
UG Healthcare Corp. Ltd. News
8K7 FAQ
What was UG Healthcare Corp. Ltd.’s price range in the past 12 months?
UG Healthcare Corp. Ltd. lowest share price was S$0.07 and its highest was S$0.11 in the past 12 months.
What is UG Healthcare Corp. Ltd.’s market cap?
UG Healthcare Corp. Ltd.’s market cap is S$48.66M.
When is UG Healthcare Corp. Ltd.’s upcoming earnings report date?
UG Healthcare Corp. Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 25 days.
How were UG Healthcare Corp. Ltd.’s earnings last quarter?
UG Healthcare Corp. Ltd. released its earnings results on Feb 11, 2026. The company reported -S$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.002.
Is UG Healthcare Corp. Ltd. overvalued?
According to Wall Street analysts UG Healthcare Corp. Ltd.’s price is currently Overvalued.
Does UG Healthcare Corp. Ltd. pay dividends?
UG Healthcare Corp. Ltd. pays a Notavailable dividend of S$0.003 which represents an annual dividend yield of N/A. See more information on UG Healthcare Corp. Ltd. dividends here
What is UG Healthcare Corp. Ltd.’s EPS estimate?
UG Healthcare Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does UG Healthcare Corp. Ltd. have?
UG Healthcare Corp. Ltd. has 623,825,800 shares outstanding.
What happened to UG Healthcare Corp. Ltd.’s price movement after its last earnings report?
UG Healthcare Corp. Ltd. reported an EPS of -S$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of UG Healthcare Corp. Ltd.?
Currently, no hedge funds are holding shares in SG:8K7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UG Healthcare Corp. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.01%
Trailing 12-Months
Company Description
UG Healthcare Corp. Ltd.
UG Healthcare Corporation Limited, an investment holding company established in Singapore in 1989, primarily engages in the manufacturing and worldwide distribution of disposable gloves. Its business is structured across three main segments: Latex Examination Gloves, Nitrile Examination Gloves, and a category for Other Ancillary Products. The company's offerings include both latex examination gloves, available in single and double chlorinated polymer-coated varieties, as well as nitrile examination gloves. Additionally, it supplies a range of supplementary items like surgical gloves, vinyl and cleanroom disposable gloves, face masks, various other medical disposables, and protective shoe covers. The firm also extends its expertise through business and management consultancy services. Its products serve diverse sectors such as healthcare, food and beverage, industrial and high-technology manufacturing, automotive, research and development, and the beauty industry. Operating under its "Unigloves" brand name, the corporation reaches customers across Malaysia, Europe, North America, South America, Africa, and the broader Asian market.
Technical Analysis
Hyphens Pharma International Ltd.
―
Asiamedic Limited
―
Medtecs International Corporation Ltd.
―
Alliance Healthcare Group Ltd.
―
Medinex Ltd.
―